A Long-Term Study of Bivamelagon in Participants With Hypothalamic Obesity (HO)
Clinical trial NCT07156578 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07156578
- Sponsor
- Rhythm Pharmaceuticals, Inc.
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-10
- Primary completion
- 2028-04-15
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.